Sky Century Investment (SKYI) Total Current Liabilities (2013 - 2026)
Sky Century Investment's (SKYI) quarterly Total Current Liabilities came in at $356253.0 in Q2 2026, down 4.83% year-on-year from $374339.0 in Q2 2025, and down 14.48% on a QoQ basis from $416593.0 in Q1 2026.
Sky Century Investment (SKYI) Total Current Liabilities (2013 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has 5 years of Total Current Liabilities data on file, last reported at $356253.0 in Q2 2026.
- On a quarterly basis, Total Current Liabilities fell 4.83% year-over-year to $356253.0 in Q2 2026; TTM through May 2026 was $356253.0, a 4.83% decrease from a year earlier, with the FY2025 full-year figure at $397449.0, up 35.67% from the prior year.
- Total Current Liabilities for Q2 2026 stood at $356253.0, down from $416593.0 in the prior quarter.
- Over the last five years, Total Current Liabilities for SKYI reached as high as $427443.0 in Q4 2025 and fell as low as $292960.0 in Q3 2024.
- Historically, Total Current Liabilities has averaged $366535.7 across 3 years, with a median of $374339.0 in 2025.
- On a YoY basis, Total Current Liabilities climbed as much as 38.54% in 2026 and fell as far as 4.83% in 2026.
- Year by year, Total Current Liabilities stood at $292960.0 in 2024, then jumped by 45.9% to $427443.0 in 2025, then dropped by 16.65% to $356253.0 in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $356253.0 in Q2 2026, $416593.0 in Q1 2026, and $427443.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Sky Century Investment | 1.06 Mn | 1.06 Mn | 26,045.00 | 356,253.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 356,253.00 |
| Feb 28, 2026 | 416,593.00 |
| Nov 30, 2025 | 427,443.00 |
| Aug 31, 2025 | 397,449.00 |
| May 31, 2025 | 374,339.00 |
| Feb 28, 2025 | 300,713.00 |
| Aug 31, 2024 | 292,960.00 |
| Aug 31, 2014 | 40,710.00 |
| May 31, 2014 | 32,280.00 |
| Feb 28, 2014 | 26,700.00 |
| Nov 30, 2013 | 27,000.00 |
| Aug 31, 2013 | 22,200.00 |
| May 31, 2013 | 14,000.00 |